Your session is about to expire
← Back to Search
Parental Education for Child Development (CANDO Trial)
N/A
Recruiting
Led By Ruchi S Gupta, MD MPH
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Infant <26 weeks of age at enrollment
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ≈36 months of age
Awards & highlights
CANDO Trial Summary
This trial will provide parents with education and resources on aspects of infant care including sleep, nutrition, building a healthy relationship with their baby, and healthy screen time use in order to promote healthy development.
Who is the study for?
This trial is for parents/guardians of infants under 26 weeks old who are in good health and can give informed consent in English or Spanish. The family should be willing to follow the study's procedures, not planning to move away before the child turns one year old, and open to being randomly assigned to a group.Check my eligibility
What is being tested?
The study aims to see if providing health education on infant care (like sleep habits, nutrition, bonding with your baby, and screen time) can influence childhood development positively. Parents will be split into two groups: one receiving this intervention and another serving as a control.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments or drugs, there are no direct side effects associated with it. However, changes in routine based on the guidance provided could indirectly affect both the infant's and parent's daily routines.
CANDO Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My baby is younger than 26 weeks old.
CANDO Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ ≈36 months of age
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~≈36 months of age
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
One year Assessment
Secondary outcome measures
Three year assessment
Two year assessment
CANDO Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
The intervention group will receive education about nutrition, resources, and specific instructions on promoting healthy development of their infant, including guidance regarding infant sleep, screen time, and building healthy relationships.
Group II: ControlPlacebo Group1 Intervention
The control group will receive specific instructions on promoting healthy development of their infant, including guidance regarding infant sleep, screen time, and building healthy relationships.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intervention
2011
Completed Phase 4
~73780
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
915,431 Total Patients Enrolled
1 Trials studying Environmental Exposures
Food Allergy Research & EducationOTHER
5 Previous Clinical Trials
29,290 Total Patients Enrolled
Ruchi S Gupta, MD MPHPrincipal InvestigatorNorthwestern University Feinberg School of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am unwilling to introduce peanut, milk, egg, or cashew into my diet.I have a health condition that requires a special diet.I can provide informed consent in English or Spanish.I was assigned male or female at birth.I have a health condition that makes it hard for me to eat solid foods.My baby is younger than 26 weeks old.I am willing to be assigned randomly to a treatment or control group.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are being admitted to this clinical study?
"Affirmative. Clinicaltrials.gov suggests that this research, which was initially posted on March 3rd 2022, is currently in the process of recruiting volunteers. 1 clinical site requires 1800 participants to take part in the trial."
Answered by AI
Is this medical trial still available to participants?
"Affirmative. According to clinicaltrials.gov, this investigation is currently recruiting patients and has been since March 3rd 2022. This research is looking for 1,800 individuals at a single medical site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger